当前位置:首页 - 行情中心 - 中红医疗(300981) - 财务分析 - 现金流量表

中红医疗

(300981)

  

流通市值:62.57亿  总市值:68.28亿
流通股本:3.93亿   总股本:4.29亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,403,235,945.16608,106,559.182,398,197,315.081,755,371,866.76
  收到的税费返还89,995,412.1855,904,447.62149,734,422.01126,441,547.88
  收到其他与经营活动有关的现金36,806,815.5435,626,007.9392,789,135.24105,148,293.51
  经营活动现金流入小计1,530,038,172.88699,637,014.732,640,720,872.331,986,961,708.15
  购买商品、接受劳务支付的现金980,097,125.25462,936,445.671,955,607,978.611,518,517,607.85
  支付给职工以及为职工支付的现金198,910,221.93100,888,186.63400,846,683.84299,081,573.33
  支付的各项税费24,448,916.8210,206,399.8454,052,268.5845,862,422.73
  支付其他与经营活动有关的现金115,559,927.6367,131,094.32226,478,257.17214,166,479.45
  经营活动现金流出小计1,319,016,191.63641,162,126.462,636,985,188.22,077,628,083.36
  经营活动产生的现金流量净额211,021,981.2558,474,888.273,735,684.13-90,666,375.21
二、投资活动产生的现金流量:
  收回投资收到的现金8,138,678,330.991,648,022,522.117,458,692,469.624,819,474,084.52
  取得投资收益收到的现金36,014,894.0715,401,165.7997,443,750.4444,429,635.04
  处置固定资产、无形资产和其他长期资产收回的现金净额158,969.6290,000648,8700
  收到的其他与投资活动有关的现金-013,328,708.4813,434,764.81
  投资活动现金流入小计8,174,852,194.681,663,513,687.97,570,113,798.544,877,338,484.37
  购建固定资产、无形资产和其他长期资产支付的现金26,345,146.1521,716,751.69190,629,442.96120,619,061.3
  投资支付的现金8,817,466,264.361,606,713,046.196,998,037,644.964,733,050,661.3
  取得子公司及其他营业单位支付的现金-00109,878,068.45
  支付其他与投资活动有关的现金1,888.25626.034,446,745.3113,891,871.19
  投资活动现金流出小计8,843,813,298.761,628,430,423.917,193,113,833.234,977,439,662.24
  投资活动产生的现金流量净额-668,961,104.0835,083,263.99376,999,965.31-100,101,177.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,235,781.57-23,061,298.66-
  其中:子公司吸收少数股东投资收到的现金3,235,781.57-23,061,298.66-
  取得借款收到的现金996,038,558.94657,001,647.681,146,180,094.881,066,698,053.13
  收到其他与筹资活动有关的现金-0140,4390
  筹资活动现金流入小计999,274,340.51657,001,647.681,169,381,832.541,066,698,053.13
  偿还债务支付的现金796,413,233.67332,057,503.42768,931,448.99555,559,089.4
  分配股利、利润或偿付利息支付的现金169,744,810.388,538,459.93129,144,389.45121,347,246.19
  其中:子公司支付给少数股东的股利、利润1,703,749.53-2,638,554.62,638,554.61
  支付其他与筹资活动有关的现金645,602.56363,801.2820,464,657.092,335,190.13
  筹资活动现金流出小计966,803,646.61340,959,764.63918,540,495.53679,241,525.72
  筹资活动产生的现金流量净额32,470,693.9316,041,883.05250,841,337.01387,456,527.41
四、汇率变动对现金及现金等价物的影响-5,102,019.711,276,862.77-20,975,645.278,688,992.34
五、现金及现金等价物净增加额-430,570,448.64410,876,898.08610,601,341.18205,377,966.67
  加:期初现金及现金等价物余额1,187,554,072.51,187,554,072.5576,952,731.32576,952,731.32
  期末现金及现金等价物余额756,983,623.861,598,430,970.581,187,554,072.5782,330,697.99
补充资料:
  净利润158,533,018.48--116,477,303.09-
  资产减值准备14,853,032.3-128,940,220.92-
  固定资产和投资性房地产折旧93,026,281.38-203,945,524.06-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧93,026,281.38-203,945,524.06-
  无形资产摊销6,265,525.05-12,383,183.19-
  长期待摊费用摊销2,032,595.43-1,935,786.81-
  处置固定资产、无形资产和其他长期资产的损失14,740.3--730,748.03-
  固定资产报废损失1,500,942.01-1,080,833.52-
  公允价值变动损失-30,608,278.55--42,862,607.01-
  财务费用23,464,916.16-52,001,514.37-
  投资损失-22,988,860.89--26,579,311.86-
  递延所得税4,647,546.91--11,537,892.92-
  其中:递延所得税资产减少4,266,009.67--7,922,496.04-
    递延所得税负债增加381,537.24--3,615,396.88-
  存货的减少-60,432,257.29--77,607,015.14-
  经营性应收项目的减少-105,932,892.21-42,430,441.02-
  经营性应付项目的增加123,041,785.16--170,080,695.67-
  现金的期末余额756,983,623.86-1,187,554,072.5-
  减:现金的期初余额1,187,554,072.5-576,952,731.32-
  现金及现金等价物的净增加额-430,570,448.64-610,601,341.18-
公告日期2026-08-262026-04-272026-04-272025-10-29
审计意见(境内)标准无保留意见
TOP↑